Shanghai UniXell Biotechnology

BiotechnologyAngelShanghai, China

Latest round

Angel

Last raised

Aug 2021

Total raised

Undisclosed

Investors

2

About Shanghai UniXell Biotechnology

Based in Shanghai, China, and founded in 2021, Shanghai UniXell Biotechnology operates as a biotechnology company that develops cell therapies for the treatment of various diseases. UniXell offers human pluripotent stem cell (hPSC) technology used for illness simulation and cell replacement therapy. The company develops a pipeline of cell therapies to treat tumors, rare diseases, and neurological disorders like Parkinson's disease, Alzheimer's disease, and stroke.

Who invested in Shanghai UniXell Biotechnology

2 investors across 1 round

See all investors in Shanghai UniXell Biotechnology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Aug 1, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Shanghai UniXell Biotechnology

Who invested in Shanghai UniXell Biotechnology?

Shanghai UniXell Biotechnology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Shanghai UniXell Biotechnology raised?

Shanghai UniXell Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Shanghai UniXell Biotechnology last raise money?

Shanghai UniXell Biotechnology's most recent round on record is a Angel, in Aug 2021.

What does Shanghai UniXell Biotechnology do?

Based in Shanghai, China, and founded in 2021, Shanghai UniXell Biotechnology operates as a biotechnology company that develops cell therapies for the treatment of various diseases.

Where is Shanghai UniXell Biotechnology headquartered?

Shanghai UniXell Biotechnology is headquartered in Shanghai, China.

Which VCs invest in companies like Shanghai UniXell Biotechnology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Shanghai UniXell Biotechnology's stage. Their profiles are linked below.

Raising like Shanghai UniXell Biotechnology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.